INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer | News & Awards - China Medical University Hospital

Other Hospital CMUH APP icon

About CMUH

News and Award

:::

News and Award/

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

About CMUH

2026/2/3

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

回上頁

Related Articles

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer img

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer img

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study img

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Stay connected with CMUH

youtube

How to get to CMUH the map of hospital

Download

▲

百度搜狗 360搜索扒了任天堂10多年财报，我终于理解了NS2的逆天定价深交所副总经理唐瑞：服务中长期资金入市，落地便利银行理财、险资参与打新及定增政策所谓“对等关税”是“开错方、吃错药”，中方在WTO发言引发广泛呼应网传京东不允许喜茶进办公区域成都独角兽，83亿卖了

<code id='caacf'></code><style id='7a679'></style>

<acronym id='06570'></acronym>

<center id='3ac22'><center id='046f0'><tfoot id='109d5'></tfoot></center><abbr id='977d1'><dir id='01332'><tfoot id='f0b9e'></tfoot><noframes id='330eb'>

<optgroup id='c7c95'><strike id='393a2'><sup id='d90c5'></sup></strike><code id='ae544'></code></optgroup>

<b id='04290'><label id='7211a'><select id='8827e'><dt id='f57e0'><span id='da5e1'></span></dt></select></label></b><u id='014a0'></u>

~~<i id='624b5'><strike id='6a65f'><tt id='9decb'><pre id='bf0c1'></pre></tt></strike></i>~~